Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8881-8890 Newer>

Pharmaceutical Executive July 1, 2014 Jill Wechsler	Pre-emption and States' Rights Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace.
Pharmaceutical Executive July 1, 2014	Europe Gears Up to Attack Counterfeit Medicines -- But Only Some of Them Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.
Information Today July 10, 2014	Europe PMC Gains New OA Research WHO (World Health Organization) announced an open access policy in January 2014 that now applies to all WHO research published in external books and journals.
Chemistry World July 9, 2014 Hepeng Jia	China struggles to speed up drug reviews The China Food and Drug Administration is attempting to outsource some reviewing processes and introducing fast-track priority reviews for selected generic drugs.
Fast Company Elizabeth Segran	Too Sexy For Your Finger Splint? Here Come Fabulous, Functional Medical Accessories Daniel Vlasic says that 3-D printers allow doctors to create devices that are perfectly customized to patients' bodies.
Chemistry World July 8, 2014 Anthony King	Call for new models to pay for antibiotics Governments will need to think seriously about changing the way they pay for the drugs. That's the conclusion of a report from the UK House of Commons science and technology committee.
Chemistry World July 8, 2014 Phillip Broadwith	First of a new breed of anticancer antibodies approved in Japan Ono pharmaceuticals' Opdivo (nivolumab) has been approved for treating melanomas where surgery is impossible.
Chemistry World July 3, 2014 Maria Burke	Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK.
Chemistry World July 3, 2014 Andy Extance	EMA wrangles restrain trial data progress Tempers are being tested as the pharmaceutical industry's journey towards transparency on clinical trial data enters a critical phase.
Chemistry World July 2, 2014 Phillip Broadwith	Genentech to buy breast cancer specialist Seragon The deal gives Genentech access to Seragon's pipeline of investigational breast cancer therapies that work by destroying estrogen receptors on the surface of cancer cells.
<Older 8881-8890 Newer> Return to current articles.